Latest filing published 02 Jun 2017 for BIOCEPT INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Timothy Kennedy: trading record in brief
This profile gathers the share dealings of Timothy Kennedy in Biocept Inc. We count 3 filings; the first trade dates from 29 July 2016 and the latest from 31 May 2017.
Purchases make up the whole of the open-market record (1 purchase, €36k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.
The newest entry dates from 2 June 2017: a share grant, in Biocept Inc. The last purchase on record was published on 21 October 2016, which is 3,670 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Timothy Kennedy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares0Common StockSEC:0001209191-17-037191:0
- 36,363 shares@ US$1.10100.0% of flowCommon StockSEC:0001209191-16-146639:0Canonical exit: 17 Jan 2017 (T+90)
- 75,000 shares0Common StockSEC:0001209191-16-134679:0
3 of 3 declarations